NEWARK, DE | The lung cancer surgery market stands at USD 1.6 billion in 2026 and is forecast to reach USD 2.8 billion by 2036, expanding at a compound annual growth rate (CAGR) of 5.9%. This sustained expansion reflects the critical role of surgical intervention in oncology, particularly for resectable early-stage non-small cell lung cancer (NSCLC), where...
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek